CBI’s management team is comprised of executives with experience in biopharmaceuticals and a proven track record for success:
Martina Vulganová, DVM., represents the company as a general director
Martina has worked in the pharmaceutical industry in various positions since 2002. During her practice, she was responsible for sales, strategy development, implementation and management of KEE managers in the hospital and prescription product segment. She possesses a profound knowledge of the healthcare system and she is also very skilled in KEE management within majorities of specializations.
As a member of an international team she participated in the development of strategy and marketing activities for EU countries.
During her practice she was involved in development of several national guidelines and recommendations.
As the general director of IMUNA PHARM, a.s. in the period of 2013-2016, she broadened her knowledge in pharmaceutical industry by all issues related to R&D, manufacturing of medicinal products, medical devices and food supplements.
She managed a few R&D projects supported by the EU (European Fund of Regional Development) in the sphere of blood derived immunologic products, vaccines and building of new manufacture that meets the world’s newest trends from the production of infusion solutions.
Her curriculum vitae was published in the Oxford Encyclopaedia in 2016.
- Over 17 years practice in the health sector
- Skilled in strategy development, communication and sales implementation
- Experienced in the company management and various teams including scientific – a natural leader easily motivating people to achieve significant results
- Fluent in English and German.
Elena Marusakova, MD., MBA, MSc. represents the company as
Responsible for quality, medical and scientific issues, RA and pharmacovigilance
Elena was working in the pharmaceutical industry in various management and leadership positions for nine years. She was responsible for coordination, preparation and implementation of pharmaceutical products registrations, pricing, categorization of medicinal products and medical devices, quality management, medical support and pharmacovigilance.
Elena is experienced in Health Technologies Assessment. Her deep knowledge comes from the past when she worked in senior management positions at the Ministry of Health of the Slovak Republic, General Health Insurance Company and Private Health Insurance Company for seven years. Since 2009 she has been lecturing pharmacoeconomics in the Slovak Medical University. Her pharmacoeconomic contributions are frequently presented as posters at ISPOR conferences. Considering Access she is excellent in legislation in Slovakia, EU countries and worldwide.
- Over 20 years’ practice in the health sector
- A specialist in elaborating pharmacoeconomic analyses and marketing of new medicinal products
- An inspirational team leader motivating people to achieve established goals
- Fluent in English, Spanish, Italian and Russian.